Excellent Research and Technologies for the Medicine of the Future
For around 100 years, Berlin-Buch has been renowned for its hospitals and cutting-edge research and is today one of the largest biomedical locations in Germany. The health sector alone generates more than 6,000 jobs, of which almost 3,000 are in basic and clinical research institutions. The Berlin-Buch BiotechPark is one of the leading technology parks in Germany. With the support of the Berlin Senate Department for Economics, Energy and Public Enterprises, this established health care location with its clear focus on biomedicine offers life science companies and research facilities outstanding conditions for synergies and networking on an international level.
Since 1992 the German Federal Government, the state of Berlin and the European Union have invested a total of EUR 502 million in the Buch Campus.
A hallmark of the Campus Berlin-Buch is the close connection between basic and patient-oriented research. It enables the development and application of future-oriented diagnostics and therapies. The Berlin Institute of Health (BIH), founded in 2013, represents a further milestone in the development of these synergies. At the BIH, the Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC) and the Charité – Universitätsmedizin Berlin, one of the largest university hospitals in Europe, combine their translational research with a focus on the interdisciplinary approach of systems medicine. This model for enhanced cooperation between world-class university-based and independent research will not only provide a stimulus to the development of the Berlin-Buch site, but also to Berlin’s regional economy and the capital region’s profile as a scientific location.
At present, the Senate Department is supporting project planning and implementation to build or expand existing traffic links, not only consolidating the location’s integration into the supra-regional infrastructure, but also opening up commercial sites to further enhance the site’s appeal.
The green campus, home to a vibrant international community, is oriented on sustainability and is experiencing continual growth. Additional research buildings are being erected, and new technology platforms are being created. In 2019, construction will begin for the next BioMed start-up factory with around 10,000 square meters of office and laboratory space.
- Between the Buch S-Bahn station and the city border, Robert-Rössle-Strasse
- Life Sciences
- Health Sector
- Medical Technology
Science and Biotech Park “Campus Berlin-Buch”
Employees: approximately 3,000
Non-university Research Institutions
- Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC)
- Leibniz-Institut für Molekulare Pharmakologie (FMP)
- Berlin Institute of Health (BIH)
- Experimental and Clinical Research Center (ECRC)
- German Centre for Cardiovascular Research (DZHK)
University Research Institution
- Charitè – Universitätsmedizin Berlin
Biotechpark Berlin-Buch with Innovation and Incubation CenterCompanies: 63 Selection:
- Eckert & Ziegler AG
- Silence Therapeutics GmbH
- Glycotope GmbH
- Experimental Pharmacology & Oncology Berlin-Buch GmbH
- MRI.TOOLS GmbH
- Celares GmbH
- STRATEC Molecular GmbH
- BioTeZ GmbH
- AJ Innuscreen GmbH
- Congen Biotechnology GmbH
Clinics: 36 clinics or centers in 3 hospitals
Employees: approximately 3,000
- Helios Klinikum Berlin-Buch (maximum care)
- Evangelische Lungenklinik Berlin (specialized hospital for lung diseases)
- Immanuel Krankenhaus Berlin-Buch (specialized hospital for rheumatic diseases)
As managing company of Campus, Campus Berlin-Buch GmbH is the partner for all companies and institutions located on campus. Its main tasks are to assist biotech companies – ranging from startups to established enterprises – in settling on campus and to provide full-service support. It is also engaged in the planning and development of the entire site to ensure an attractive campus environment.